Home / Cloud Computing / Cloud Computing: Nvidia acquires data storage and management platform SwiftStack

Cloud Computing: Nvidia acquires data storage and management platform SwiftStack

Cloud Computing:

announced that it has acquired SwiftStack, a software-centric data storage and management platform that supports public cloud, on-premises and edge deployments.” data-reactid=”12″ type=”text”>Nvidia today announced that it has acquired SwiftStack, a software-centric data storage and management platform that supports public cloud, on-premises and edge deployments.

The company’s recent launches focused on improving its support for AI, high-performance computing and accelerated computing workloads, which is surely what Nvidia is most interested in here.

Mayfield Fund and OpenView Venture Partners. Other investors include Storm Ventures and UMC Capital.” data-reactid=”15″ type=”text”>The two companies did not disclose the price of the acquisition, but SwiftStack had previously raised about $23.6 million in Series A and B rounds led by Mayfield Fund and OpenView Venture Partners. Other investors include Storm Ventures and UMC Capital.

early bet on OpenStack, the massive open-source project that aimed to give enterprises an AWS-like management experience in their own data centers. The company was one of the largest contributors to OpenStack’s Swift object storage platform and offered a number of services around this, though it seems like in recent years it has downplayed the OpenStack relationship as that platform’s popularity has fizzled in man
Read More

About admin

Check Also

Cloud Computing: D-Wave gives anyone working on responses to the COVID-19 free cloud access to its quantum computers

Cloud Computing: D-Wave gives anyone working on responses to the COVID-19 free cloud access to its quantum computers

D-Wave, the Canadian quantum computing company, today announced that it is giving anyone who is working on responses to the COVID-19 free access to its Leap 2 quantum computing cloud service. The offer isn't only valid to those focusing on new drugs but open to any research or team working on any aspect of how…

Leave a Reply

Your email address will not be published. Required fields are marked *